44 evolution "https:" "https:" "https:" "https:" "https:" "https:" "UCL" "UCL" scholarships at Leibniz in Germany
Sort by
Refine Your Search
-
The Leibniz Institute for Solid State and Materials Research Dresden e. V. (IFW Dresden) conducts modern materials research on a scientific basis for the development of new and sustainable materials
-
spectrum from basic and applied research to pre-industrial development and is carried out in cooperation with national and international partners from universities, academies and industry. The institute is
-
for Precision Medicine”, with focus on the analysis and development of biomarker profiles for the personalized assessment of cardiovascular risks associated with cancer therapy. You will be responsible
-
on the analysis and development of biomarker profiles for the personalized assessment of cardiovascular risks associated with cancer therapy. You will be responsible for: Analysis of longitudinal blood, plasma, and
-
on the analysis and development of biomarker profiles for the personalized assessment of cardiovascular risks associated with cancer therapy. You will be responsible for: Analysis of murine tissue samples (heart
-
on the analysis and development of biomarker profiles for the personalized assessment of cardiovascular risks associated with cancer therapy. You will be responsible for: Conducting proteomic analyses of blood
-
factors controlling barb and trichome development in barley, investigate the pleiotropic effects of the two awn roughness genes Raw1 and Raw7 at the whole-plant level, understanding the roles of the genes
-
your online-application as one single pdf-file (http://www.ipk-gatersleben.de/en/job-offers/) by 25.05.2026. If you have questions or require more information, please contact Kerstin Schweigert (jobs
-
spectrum from basic and applied research to pre-industrial development and is carried out in cooperation with national and international partners from universities, academies and industry. The institute is
-
-HEART Consortium: Method development to quantify very low-concentrated proteins in human blood plasma, e.g. using targeted LC-/MS/MS methods to detect interleukins Continuous development of existing